EPICS Therapeutics logo

EPICS Therapeutics

EPICS is a drug discovery and development company for small molecule drugs targeting RNA epigenetic mecanisms of cancer

26 employees · est. 2018 · Belgium

VS
Hyperway Pharmaceuticals logo

Hyperway Pharmaceuticals

A biotech startup focused on small molecule drug discovery

1 employees · est. 2019 · Chengdu, China

EPICS Therapeutics is the older company (2018 vs 2019); EPICS Therapeutics is the larger of the two.

Side-by-Side Comparison

EPICS Therapeutics Hyperway Pharmaceuticals
Founded
2018 older 2019
Headquarters
Belgium Chengdu, China
Employees
26 larger 1
Industry
Biopharma, Health Care Health Care, Pharmaceutical
Funding Stage
Seed Series A
Total Funding
$7.20M $100.00M
Funding Rounds
1 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Drug Delivery, Cancer Therapeutics, RNA Epigenetics, Small Molecule Drugs, Oncology Research Pharmaceutical R&D, High-end APIs, Innovation, Research And Development, Small Molecule Drugs, High-Tech Advancements, Global Platform, Drug Development, Management, Fortune 500 Companies, Clinical Trials, Chengdu, Sichuan Province, Domestic Pharmaceutical Companies, Expertise, Generic Medications
Website
epicstherapeutics.com hyperwaypharma.com
EPICS Therapeutics logo

About EPICS Therapeutics

Epic Therapeutics is a biopharmaceutical startup based in Belgium, founded in 2018. The company is focused on developing small molecule drugs targeting RNA epigenetic mechanisms involved in cancer. Its mission is to address unmet medical needs in oncology by inventing novel clinical agents. The rece...

Hyperway Pharmaceuticals logo

About Hyperway Pharmaceuticals

Hyperway Pharm is a pharmaceutical research and production enterprise with a strong focus on innovation and excellence. Founded in 2019, the company is dedicated to pioneering small molecule drugs and high-end APIs with a commitment to technological advancements in the Health Care and Pharmaceutical...

We will tell you when either one moves

BounceWatch watches EPICS Therapeutics and Hyperway Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EPICS Therapeutics and Hyperway Pharmaceutica... — by email.

Frequently Asked Questions

EPICS Therapeutics — EPICS is a drug discovery and development company for small molecule drugs targeting RNA epigenetic mecanisms of cancer. Hyperway Pharmaceuticals — A biotech startup focused on small molecule drug discovery. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EPICS Therapeutics has raised $7.20M while Hyperway Pharmaceuticals has raised $100.00M.
EPICS Therapeutics and Hyperway Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EPICS Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at EPICS Therapeutics on 11 Sep 2024, and Hyperway Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy